SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Symbiotec Pharmalab files preliminary papers to raise Rs 2,180 crore via IPO

20 Dec 2025 Evaluate

Symbiotec Pharmalab has filed preliminary papers with capital markets regulator-- Securities and Exchange Board of India’s (SEBI) to raise Rs 2,180 crore through its initial public offering (IPO).

The company's maiden public offering will be a combination of a fresh issue of shares worth Rs 150 crore, along with an offer for sale (OFS) of Rs 2,030 crore by a promoters and existing investors. As a part of the OFS, promoter -- Satwani Holdings LLP and investors -- Rosewood Investments, and India Business Excellence Fund-III will offload shares.

At present, Rosewood Investments and India Business Excellence Fund together hold over 66 per cent stake in the pharma firm. Proceeds of the fresh issue will be used for debt payment and general corporate purposes. The Indore-based Symbiotec is a research and development-driven, pharmaceutical and biotechnology company with capabilities across three platforms-organic chemistry, biotechnology and complex injectables.

Symbiotec Pharmalab is  a research and development-driven, science-based pharmaceutical and biotechnology company with capabilities across three platforms- organic chemistry, biotechnology and complex injectables.

Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×